The City Planning Commission voted Wednesday to approve a rezoning application from the New York Blood Center to turn its Upper East Side facility into a $750 million hub for life sciences research and development.
The nonprofit’s project is a partnership with developer Longfellow Real Estate Partners of Boston to replace its East 67th Street center with a 16-story, 596,000-square-foot building that would include space for life sciences tenants. The Blood Center has said the redevelopment will enable it to double its research space and potentially increase blood collection by a third.
Wednesday’s 8–2 vote checks off one of the final steps in the city’s land-use review process.
→ Continue reading at Crain's New York Business